MP-2021

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMP-2021
Drug Alias NameMP-2021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitors
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesArthritis, RheumatoidArthritis, Psoriatic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedpacto Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedpacto Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesArthritis, RheumatoidArthritis, Psoriatic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A